{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:44:00Z","timestamp":1788371040502,"version":"build-2803163510"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:00:00Z","timestamp":1669248000000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009469","name":"Centre-Val de Loire Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006298","name":"Graduate College, University of Illinois at Urbana-Champaign","doi-asserted-by":"publisher","award":["2338"],"award-info":[{"award-number":["2338"]}],"id":[{"id":"10.13039\/100006298","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010564","name":"Deutsches Zentrum f\u00fcr Lungenforschung","doi-asserted-by":"publisher","award":["394046635 -SFB 1365"],"award-info":[{"award-number":["394046635 -SFB 1365"]}],"id":[{"id":"10.13039\/501100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010564","name":"Deutsches Zentrum f\u00fcr Lungenforschung","doi-asserted-by":"publisher","award":["KE 576\/10-1"],"award-info":[{"award-number":["KE 576\/10-1"]}],"id":[{"id":"10.13039\/501100010564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007526","name":"Universit\u00e9 Fran\u00e7ois-Rabelais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007526","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004792","name":"Minist\u00e8re de l&apos;Enseignement Sup\u00e9rieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bcp.2021.114803","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T12:17:44Z","timestamp":1634818664000},"page":"114803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Cathepsin C inhibition as a potential treatment strategy in cancer"],"prefix":"10.1016","volume":"194","author":[{"given":"Brice","family":"Korkmaz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Lamort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxane","family":"Domain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6987-3120","authenticated-orcid":false,"given":"C\u00e9line","family":"Beauvillain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Gieldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali \u00d6nder","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios T.","family":"Stathopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moez","family":"Rhimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter E.","family":"Jenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5821-6718","authenticated-orcid":false,"given":"Ralph","family":"Kettritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.bcp.2021.114803_b0010","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S1470-2045(19)30329-8","article-title":"5-year overall survival in patients with lung cancer eligible or ineligible for screening according to US Preventive Services Task Force criteria: a prospective, observational cohort study","volume":"20","author":"Luo","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2021.114803_b0015","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3390\/cancers10080248","article-title":"Lung cancers: molecular characterization, clonal heterogeneity and evolution, and cancer stem cells","volume":"10","author":"Testa","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"13","key":"10.1016\/j.bcp.2021.114803_b0020","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.3390\/ijms21134569","article-title":"Genetic markers in lung cancer diagnosis: a review","volume":"21","author":"Wadowska","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2021.114803_b0025","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2021.114803_b0035","unstructured":"A. Jamil, A. Kasi, Lung Metastasis, StatPearls, Treasure Island (FL), 2021."},{"issue":"6409","key":"10.1016\/j.bcp.2021.114803_b0040","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao4227","article-title":"Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice","volume":"361","author":"Albrengues","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.bcp.2021.114803_b0045","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.3389\/fimmu.2019.01720","article-title":"NAD-biosynthetic and consuming enzymes as central players of metabolic regulation of innate and adaptive immune responses in cancer","volume":"10","author":"Audrito","year":"2019","journal-title":"Front. Immunol."},{"issue":"33","key":"10.1016\/j.bcp.2021.114803_b0050","doi-asserted-by":"crossref","first-page":"12493","DOI":"10.1073\/pnas.0601807103","article-title":"Infiltrating neutrophils mediate the initial angiogenic switch in a mouse model of multistage carcinogenesis","volume":"103","author":"Nozawa","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.bcp.2021.114803_b0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nm.2084","article-title":"Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth","volume":"16","author":"Houghton","year":"2010","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.bcp.2021.114803_b0060","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1158\/0008-5472.CAN-15-1591","article-title":"Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress","volume":"76","author":"Tohme","year":"2016","journal-title":"Cancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2021.114803_b0065","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1073\/pnas.0712185105","article-title":"Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression","volume":"105","author":"Shojaei","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.bcp.2021.114803_b0070","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41523-020-00212-6","article-title":"Effects of systemic inflammation on relapse in early breast cancer","volume":"7","author":"McAndrew","year":"2021","journal-title":"npj Breast Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0075","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41416-018-0360-y","article-title":"Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer","volume":"120","author":"Varkaris","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"31","key":"10.1016\/j.bcp.2021.114803_b0080","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.3748\/wjg.v25.i31.4383","article-title":"Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance","volume":"25","author":"Tuomisto","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcp.2021.114803_b0085","unstructured":"."},{"issue":"8","key":"10.1016\/j.bcp.2021.114803_b0090","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.3909","article-title":"The prognostic landscape of genes and infiltrating immune cells across human cancers","volume":"21","author":"Gentles","year":"2015","journal-title":"Nat. Med."},{"issue":"19\u201320","key":"10.1016\/j.bcp.2021.114803_b0095","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1101\/gad.314617.118","article-title":"Roles of the immune system in cancer: from tumor initiation to metastatic progression","volume":"32","author":"Gonzalez","year":"2018","journal-title":"Genes Dev."},{"issue":"9","key":"10.1016\/j.bcp.2021.114803_b0100","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/ATVBAHA.119.312463","article-title":"Neutrophil extracellular traps: villains and targets in arterial, venous, and cancer-associated thrombosis","volume":"39","author":"Thalin","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"5663","key":"10.1016\/j.bcp.2021.114803_b0105","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"issue":"22","key":"10.1016\/j.bcp.2021.114803_b0110","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/eurheartj\/ehv105","article-title":"Neutrophil extracellular traps: a new source of tissue factor in atherothrombosis","volume":"36","author":"Badimon","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2021.114803_b0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.biopha.2016.12.021","article-title":"Role of protease and protease inhibitors in cancer pathogenesis and treatment","volume":"86","author":"Eatemadi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2021.114803_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2019.02.003","article-title":"Cathepsins: Potent regulators in carcinogenesis","volume":"198","author":"Khaket","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.bcp.2021.114803_b0125","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nrc4027","article-title":"Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response","volume":"15","author":"Olson","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.bcp.2021.114803_b0130","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1002\/eji.201141538","article-title":"Extracellular proteolysis in macrophage migration: losing grip for a breakthrough","volume":"41","author":"Verollet","year":"2011","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.bcp.2021.114803_b0135","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2174\/138161209787846676","article-title":"A fresh prospect of extracellular matrix hydrolytic enzymes and their substrates","volume":"15","author":"Roycik","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"4-5","key":"10.1016\/j.bcp.2021.114803_b0140","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1080\/13813450601093567","article-title":"Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue","volume":"112","author":"Christiaens","year":"2006","journal-title":"Arch. Physiol. Biochem."},{"issue":"12","key":"10.1016\/j.bcp.2021.114803_b0145","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1038\/sj.bjc.6602630","article-title":"Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues","volume":"92","author":"Riddick","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.bcp.2021.114803_b0150","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/nrd4390","article-title":"Is there new hope for therapeutic matrix metalloproteinase inhibition?","volume":"13","author":"Vandenbroucke","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.bcp.2021.114803_b0155","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1124\/pr.110.002733","article-title":"Neutrophil elastase, proteinase 3 and cathepsin G as therapeutic targets in human diseases","volume":"62","author":"Korkmaz","year":"2010","journal-title":"Pharmacol. Rev."},{"issue":"2","key":"10.1016\/j.bcp.2021.114803_b0160","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.biochi.2007.10.009","article-title":"Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions","volume":"90","author":"Korkmaz","year":"2008","journal-title":"Biochimie"},{"issue":"16","key":"10.1016\/j.bcp.2021.114803_b0165","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1073\/pnas.1200470109","article-title":"NSP4, an elastase-related protease in human neutrophils with arginine specificity","volume":"109","author":"Perera","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bcp.2021.114803_b0170","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.4049\/jimmunol.1301293","article-title":"NSP4 is stored in azurophil granules and released by activated neutrophils as active endoprotease with restricted specificity","volume":"191","author":"Perera","year":"2013","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0175","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1124\/pr.115.012104","article-title":"Inhibitors and antibody fragments as potential anti-inflammatory therapeutics targeting neutrophil proteinase 3 in human disease","volume":"68","author":"Korkmaz","year":"2016","journal-title":"Pharmacol. Rev."},{"issue":"32","key":"10.1016\/j.bcp.2021.114803_b0180","doi-asserted-by":"crossref","first-page":"13076","DOI":"10.1073\/pnas.1200419109","article-title":"Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis","volume":"109","author":"Demers","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"36","key":"10.1016\/j.bcp.2021.114803_b0185","doi-asserted-by":"crossref","first-page":"15880","DOI":"10.1073\/pnas.1005743107","article-title":"Extracellular DNA traps promote thrombosis","volume":"107","author":"Fuchs","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"45","key":"10.1016\/j.bcp.2021.114803_b0190","doi-asserted-by":"crossref","first-page":"E9618","DOI":"10.1073\/pnas.1708247114","article-title":"Necroptosis controls NET generation and mediates complement activation, endothelial damage, and autoimmune vasculitis","volume":"114","author":"Schreiber","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0195","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1083\/jcb.201006052","article-title":"Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps","volume":"191","author":"Papayannopoulos","year":"2010","journal-title":"J. Cell Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0200","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.celrep.2014.06.044","article-title":"A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis","volume":"8","author":"Metzler","year":"2014","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.bcp.2021.114803_b0205","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3390\/ijms22041658","article-title":"Origin and expansion of the serine protease repertoire in the myelomonocyte lineage","volume":"22","author":"Weiss","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2021.114803_b0210","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00109-010-0677-3","article-title":"Tailor-made inflammation: how neutrophil serine proteases modulate the inflammatory response","volume":"89","author":"Kessenbrock","year":"2011","journal-title":"J. Mol. Med. (Berl.)"},{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0215","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1681\/ASN.2010080892","article-title":"Neutrophil serine proteases promote IL-1beta generation and injury in necrotizing crescentic glomerulonephritis","volume":"23","author":"Schreiber","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcp.2021.114803_b0220","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.pharmthera.2018.05.011","article-title":"Therapeutic targeting of cathepsin C: from pathophysiology to treatment","volume":"190","author":"Korkmaz","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.bcp.2021.114803_b0225","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/imr.12441","article-title":"Neutral serine proteases of neutrophils","volume":"273","author":"Kettritz","year":"2016","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.bcp.2021.114803_b0230","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ki.2015.159","article-title":"Neutrophil serine proteases exert proteolytic activity on endothelial cells","volume":"88","author":"Jerke","year":"2015","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.bcp.2021.114803_b0235","doi-asserted-by":"crossref","first-page":"M111","DOI":"10.1074\/mcp.M111.009449","article-title":"Profilin 1 is a potential biomarker for bladder cancer aggressiveness","volume":"11","author":"Zoidakis","year":"2012","journal-title":"Mol. Cell. Proteomics"},{"issue":"46","key":"10.1016\/j.bcp.2021.114803_b0240","doi-asserted-by":"crossref","first-page":"31777","DOI":"10.1074\/jbc.M114.591339","article-title":"New selective peptidyl di(chlorophenyl) phosphonate esters for visualizing and blocking neutrophil proteinase 3 in human diseases","volume":"289","author":"Guarino","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114803_b0245","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1471-2172-14-36","article-title":"Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease","volume":"14","author":"Vaguliene","year":"2013","journal-title":"BMC Immunol."},{"key":"10.1016\/j.bcp.2021.114803_b0250","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.steroids.2017.11.006","article-title":"Neutrophil elastase in the tumor microenvironment","volume":"133","author":"Lerman","year":"2018","journal-title":"Steroids"},{"issue":"2","key":"10.1016\/j.bcp.2021.114803_b0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1074\/mcp.M116.058818","article-title":"A strong neutrophil elastase proteolytic fingerprint marks the carcinoma tumor proteome","volume":"16","author":"Kistowski","year":"2017","journal-title":"Mol. Cell. Proteomics"},{"issue":"5","key":"10.1016\/j.bcp.2021.114803_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.03.001","article-title":"CXCR1 and CXCR2 chemokine receptor agonists produced by tumors induce neutrophil extracellular traps that interfere with immune cytotoxicity","volume":"52","author":"Teijeira","year":"2020","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.bcp.2021.114803_b0265","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.immuni.2020.04.009","article-title":"Neutrophils create an ImpeNETrable shield between tumor and cytotoxic immune cells","volume":"52","author":"Ireland","year":"2020","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.bcp.2021.114803_b0270","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"issue":"269","key":"10.1016\/j.bcp.2021.114803_b0275","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal"},{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.12.025","article-title":"Insertions and deletions target lineage-defining genes in human cancers","volume":"168","author":"Imielinski","year":"2017","journal-title":"Cell"},{"issue":"23","key":"10.1016\/j.bcp.2021.114803_b0285","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1093\/emboj\/20.23.6570","article-title":"Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases","volume":"20","author":"Turk","year":"2001","journal-title":"EMBO J."},{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0290","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1172\/JCI0213462","article-title":"Dipeptidyl peptidase I activates neutrophil-derived serine proteases and regulates the development of acute experimental arthritis","volume":"109","author":"Adkison","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.bcp.2021.114803_b0295","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.4049\/jimmunol.173.12.7277","article-title":"Papillon-Lefevre syndrome: correlating the molecular, cellular, and clinical consequences of cathepsin C\/dipeptidyl peptidase I deficiency in humans","volume":"173","author":"Pham","year":"2004","journal-title":"J. Immunol."},{"issue":"21","key":"10.1016\/j.bcp.2021.114803_b0300","doi-asserted-by":"crossref","first-page":"18551","DOI":"10.1074\/jbc.M100223200","article-title":"Dipeptidyl peptidase I is essential for activation of mast cell chymases, but not tryptases, in mice","volume":"276","author":"Wolters","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2021.114803_b0305","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.4049\/jimmunol.154.12.6299","article-title":"Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I","volume":"154","author":"Smyth","year":"1995","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114803_b0310","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1083\/jcb.200609077","article-title":"Residual active granzyme B in cathepsin C-null lymphocytes is sufficient for perforin-dependent target cell apoptosis","volume":"176","author":"Sutton","year":"2007","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114803_b0315","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1021\/bi001693z","article-title":"Human recombinant pro-dipeptidyl peptidase I (cathepsin C) can be activated by cathepsins L and S but not by autocatalytic processing","volume":"40","author":"Dahl","year":"2001","journal-title":"Biochemistry"},{"issue":"19","key":"10.1016\/j.bcp.2021.114803_b0320","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.3390\/ijms20194747","article-title":"Processing and maturation of Cathepsin C Zymogen: a biochemical and molecular modeling analysis","volume":"20","author":"Lamort","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0325","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1042\/BJ20061389","article-title":"The crystal structure of human dipeptidyl peptidase I (cathepsin C) in complex with the inhibitor Gly-Phe-CHN2","volume":"401","author":"Molgaard","year":"2007","journal-title":"Biochem. J."},{"issue":"16","key":"10.1016\/j.bcp.2021.114803_b0330","doi-asserted-by":"crossref","first-page":"8486","DOI":"10.1074\/jbc.M115.707109","article-title":"Neutrophilic cathepsin C is maturated by a multi-step proteolytic process and secreted by activated cells during inflammatory lung diseases","volume":"291","author":"Hamon","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2021.114803_b0335","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03755-2020","article-title":"Proteinase release from activated neutrophils in mechanically ventilated patients with non-COVID-19 and COVID-19 pneumonia","volume":"57","author":"Seren","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.bcp.2021.114803_b0340","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/70525","article-title":"Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis","volume":"23","author":"Toomes","year":"1999","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.bcp.2021.114803_b0345","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/jmg.36.12.881","article-title":"Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome","volume":"36","author":"Hart","year":"1999","journal-title":"J. Med. Genet."},{"issue":"32","key":"10.1016\/j.bcp.2021.114803_b0350","doi-asserted-by":"crossref","first-page":"12415","DOI":"10.1074\/jbc.RA118.001922","article-title":"Consequences of cathepsin C inactivation for membrane exposure of proteinase 3, the target antigen in autoimmune vasculitis","volume":"293","author":"Seren","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.bcp.2021.114803_b0355","doi-asserted-by":"crossref","first-page":"4539","DOI":"10.1172\/JCI76009","article-title":"Papillon-Lefevre syndrome patient reveals species-dependent requirements for neutrophil defenses","volume":"124","author":"Sorensen","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bcp.2021.114803_b0360","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1189\/jlb.5A1015-489R","article-title":"Characterization of neutrophil function in Papillon-Lefevre syndrome","volume":"100","author":"Roberts","year":"2016","journal-title":"J. Leukoc. Biol."},{"issue":"19","key":"10.1016\/j.bcp.2021.114803_b0365","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1101\/gad.224899.113","article-title":"Cathepsin C is a tissue-specific regulator of squamous carcinogenesis","volume":"27","author":"Ruffell","year":"2013","journal-title":"Genes Dev."},{"issue":"1","key":"10.1016\/j.bcp.2021.114803_b0370","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4143\/crt.2019.145","article-title":"Cathepsin C interacts with TNF-alpha\/p38 MAPK signaling pathway to promote proliferation and metastasis in hepatocellular carcinoma","volume":"52","author":"Zhang","year":"2020","journal-title":"Cancer Res. Treat."},{"issue":"8","key":"10.1016\/j.bcp.2021.114803_b0375","doi-asserted-by":"crossref","first-page":"13332","DOI":"10.1002\/jcp.28010","article-title":"Timosaponin AIII inhibits metastasis of renal carcinoma cells through suppressing cathepsin C expression by AKT\/miR-129-5p axis","volume":"234","author":"Chiang","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.bcp.2021.114803_b0380","first-page":"1304","article-title":"Decursin inhibits cell growth and autophagic flux in gastric cancer via suppression of cathepsin C","volume":"11","author":"Kim","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bcp.2021.114803_b0385","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.cellsig.2018.02.017","article-title":"Targeting of cathepsin C induces autophagic dysregulation that directs ER stress mediated cellular cytotoxicity in colorectal cancer cells","volume":"46","author":"Khaket","year":"2018","journal-title":"Cell. Signal."},{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0390","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ccell.2020.12.012","article-title":"Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation","volume":"39","author":"Xiao","year":"2021","journal-title":"Cancer Cell"},{"issue":"30","key":"10.1016\/j.bcp.2021.114803_b0395","doi-asserted-by":"crossref","first-page":"19896","DOI":"10.1074\/jbc.M901471200","article-title":"Catalytic activity and inhibition of wegener antigen proteinase 3 on the cell surface of human polymorphonuclear neutrophils","volume":"284","author":"Korkmaz","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2021.114803_b0400","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00281-013-0362-z","article-title":"Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis)","volume":"35","author":"Korkmaz","year":"2013","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.bcp.2021.114803_b0405","doi-asserted-by":"crossref","first-page":"43328","DOI":"10.1038\/srep43328","article-title":"Characterization of the CD177 interaction with the ANCA antigen proteinase 3","volume":"7","author":"Jerke","year":"2017","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2021.114803_b0410","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2004-01-0267","article-title":"Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo","volume":"104","author":"Pfister","year":"2004","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcp.2021.114803_b0415","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.intimp.2013.07.003","article-title":"Relevance of the mouse model as a therapeutic approach for neutrophil proteinase 3-associated human diseases","volume":"17","author":"Korkmaz","year":"2013","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0420","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1074\/jbc.M608700200","article-title":"Influence of charge distribution at the active site surface on the substrate specificity of human neutrophil protease 3 and elastase. A kinetic and molecular modeling analysis","volume":"282","author":"Korkmaz","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"49","key":"10.1016\/j.bcp.2021.114803_b0425","doi-asserted-by":"crossref","first-page":"34084","DOI":"10.1074\/jbc.M109.042903","article-title":"Structural characterization of mouse neutrophil serine proteases and identification of their substrate specificities: relevance to mouse models of human inflammatory diseases","volume":"284","author":"Kalupov","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2021.114803_b0430","unstructured":"B. Korkmaz, I. Keles, Cathepsin C as pharmacological target in cancer, <http:\/\/online.cancerresearch2021.org\/hibrit\/pdf\/dijital-kitap.pdf> (2021)."},{"issue":"12","key":"10.1016\/j.bcp.2021.114803_b0435","doi-asserted-by":"crossref","first-page":"5901","DOI":"10.1021\/acs.jmedchem.9b00631","article-title":"Identification and optimization of novel cathepsin C inhibitors derived from EGFR inhibitors","volume":"62","author":"Hou","year":"2019","journal-title":"J. Med. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2021.114803_b0440","doi-asserted-by":"crossref","first-page":"11857","DOI":"10.1021\/acs.jmedchem.1c00104","article-title":"Discovery and in vivo anti-inflammatory activity evaluation of a novel non-peptidyl non-covalent cathepsin C inhibitor","volume":"64","author":"Chen","year":"2021","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0445","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cells","volume":"16","author":"Miller","year":"1988","journal-title":"Nucleic Acids Res."},{"issue":"22","key":"10.1016\/j.bcp.2021.114803_b0450","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the DPP-1 inhibitor brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2021.114803_b0455","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.bcp.2019.04.006","article-title":"Structure-based design and in vivo anti-arthritic activity evaluation of a potent dipeptidyl cyclopropyl nitrile inhibitor of cathepsin C","volume":"164","author":"Korkmaz","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"20","key":"10.1016\/j.bcp.2021.114803_b0460","doi-asserted-by":"crossref","first-page":"9457","DOI":"10.1021\/acs.jmedchem.6b01127","article-title":"Discovery of second generation reversible covalent DPP1 inhibitors leading to an oxazepane amidoacetonitrile based clinical candidate (AZD7986)","volume":"59","author":"Doyle","year":"2016","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2021.114803_b0465","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.1038\/s41598-019-46206-8","article-title":"Premedication with a cathepsin C inhibitor alleviates early primary graft dysfunction in mouse recipients after lung transplantation","volume":"9","author":"Rehm","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2021.114803_b0470","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.bcp.2017.02.009","article-title":"Prolonged pharmacological inhibition of cathepsin C results in elimination of neutrophil serine proteases","volume":"131","author":"Guarino","year":"2017","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2021.114803_b0475","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/cpt.1053","article-title":"Dipeptidyl peptidase 1 inhibitor AZD7986 induces a sustained, exposure-dependent reduction in neutrophil elastase activity in healthy subjects","volume":"104","author":"Palm\u00e9r","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"issue":"18","key":"10.1016\/j.bcp.2021.114803_b0480","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMra012519","article-title":"Bronchiectasis","volume":"346","author":"Barker","year":"2002","journal-title":"N. Engl. J. Med."},{"issue":"22","key":"10.1016\/j.bcp.2021.114803_b0485","doi-asserted-by":"crossref","first-page":"13258","DOI":"10.1021\/acs.jmedchem.0c00776","article-title":"Lung protection by cathepsin C inhibition: a new hope for COVID-19 and ARDS?","volume":"63","author":"Korkmaz","year":"2020","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2021.114803_b0490","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/jmbi.1996.0458","article-title":"The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies","volume":"261","author":"Fujinaga","year":"1996","journal-title":"J. Mol. Biol."},{"issue":"18","key":"10.1016\/j.bcp.2021.114803_b0495","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/jm020881f","article-title":"Discovery of further pyrrolidine trans-lactams as inhibitors of human neutrophil elastase (HNE) with potential as development candidates and the crystal structure of HNE complexed with an inhibitor (GW475151)","volume":"45","author":"Macdonald","year":"2002","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bcp.2021.114803_b0500","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1002\/j.1460-2075.1996.tb00933.x","article-title":"The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities","volume":"15","author":"Hof","year":"1996","journal-title":"EMBO J."},{"issue":"9","key":"10.1016\/j.bcp.2021.114803_b0505","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.str.2014.07.008","article-title":"Structures of neutrophil serine protease 4 reveal an unusual mechanism of substrate recognition by a trypsin-fold protease","volume":"22","author":"Lin","year":"2014","journal-title":"Structure"},{"issue":"6","key":"10.1016\/j.bcp.2021.114803_b0510","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1165\/rcmb.2003-0139OC","article-title":"Design and use of highly specific substrates of neutrophil elastase and proteinase 3","volume":"30","author":"Korkmaz","year":"2004","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2021.114803_b0515","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/febs.13605","article-title":"Analysis of urinary cathepsin C for diagnosing Papillon-Lefevre syndrome","volume":"283","author":"Hamon","year":"2016","journal-title":"FEBS J."},{"issue":"2","key":"10.1016\/j.bcp.2021.114803_b0520","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1021\/ml100212k","article-title":"Discovery of novel cyanamide-based inhibitors of cathepsin C","volume":"2","author":"Laine","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"issue":"6116","key":"10.1016\/j.bcp.2021.114803_b0525","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1126\/science.1229663","article-title":"Natively inhibited Trypanosoma brucei cathepsin B structure determined by using an X-ray laser","volume":"339","author":"Redecke","year":"2013","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.bcp.2021.114803_b0530","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases. I. Papain","volume":"27","author":"Schechter","year":"1967","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2021.114803_b0535","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.abb.2016.10.007","article-title":"Development of the first internally-quenched fluorescent substrates of human cathepsin C: the application in the enzyme detection in biological samples","volume":"612","author":"Legowska","year":"2016","journal-title":"Arch. Biochem. Biophys."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295221004196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T15:10:22Z","timestamp":1762096222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295221004196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":106,"alternative-id":["S0006295221004196"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114803","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cathepsin C inhibition as a potential treatment strategy in cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2021.114803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114803"}}